Extremely poor postrecurrence oncological outcome for patients with recurrent mucinous ovarian cancer

 Extremely poor postrecurrence oncological outcome for patients with recurrent mucinous ovarian cancer

Abstract

BACKGROUND:

This study was conducted to assess the long-term clinical outcome for patients with recurrent mucinous epithelial ovarian cancer (RmOC) in comparison with recurrent serous epithelial ovarian cancer (RsOC).

CONCLUSIONS:

The clinical outcome after recurrence in patients with RmOC was extremely poor. This confirms that RmOC should be considered a different entity from other epithelial ovarian cancers.